These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 27323543)

  • 61. A questionnaire-based study to comprehensively assess the status quo of rare disease patients and care-givers in China.
    Li X; Liu M; Lin J; Li B; Zhang X; Zhang S; Lu Z; Zhang J; Zhou J; Ou L
    Orphanet J Rare Dis; 2021 Jul; 16(1):327. PubMed ID: 34294091
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Rare diseases: an "exceptional field of research. Interview by Catherine Holué].
    Dolfus H; Lévy N
    Rev Prat; 2012 Jan; 62(1):89-90. PubMed ID: 22335076
    [No Abstract]   [Full Text] [Related]  

  • 63. Review and comparison of clinical evidence submitted to support European Medicines Agency market authorization of orphan-designated oncological treatments.
    Winstone J; Chadda S; Ralston S; Sajosi P
    Orphanet J Rare Dis; 2015 Oct; 10():139. PubMed ID: 26511061
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Vision and challenges of a cartographic representation of expert medical centres for rare diseases.
    Storf H; Hartz T; Tegtbauer N; Pfeiffer W; Schmidtke J; Graessner H; Wagner T; Uckert F
    Stud Health Technol Inform; 2014; 205():677-81. PubMed ID: 25160272
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Orphanet and the Dutch Steering Committee Orphan Drugs. A European and Dutch databank of information on rare diseases].
    Liem SL
    Ned Tijdschr Tandheelkd; 2008 Nov; 115(11):621-3. PubMed ID: 19058507
    [TBL] [Abstract][Full Text] [Related]  

  • 66. "Creating hope" and other incentives for drug development for children.
    Connor E; Cure P
    Sci Transl Med; 2011 Jan; 3(66):66cm1. PubMed ID: 21248312
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [The actual questions of the care of rare diseases].
    Pogány G
    Orv Hetil; 2017 Nov; 158(47):1851-1856. PubMed ID: 29153019
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Managing drugs for rare genetic diseases: trends and insights.
    Zitter M
    Manag Care; 2005 Feb; 14(2):52-4, 57-60, 63-4; quiz 66-7. PubMed ID: 15782848
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Health and medical care in Ethiopia.
    Hodes RM; Kloos H
    N Engl J Med; 1988 Oct; 319(14):918-24. PubMed ID: 3419456
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Taking health promotion on to the streets.
    Filgueiras A
    AIDS Action; 1992 Jun; (17):7. PubMed ID: 12285897
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rare diseases and effective treatments: are we delivering?
    Luzzatto L; Hollak CE; Cox TM; Schieppati A; Licht C; Kääriäinen H; Merlini G; Schaefer F; Simoens S; Pani L; Garattini S; Remuzzi G
    Lancet; 2015 Feb; 385(9970):750-2. PubMed ID: 25752159
    [No Abstract]   [Full Text] [Related]  

  • 72. Access to social services for undiagnosed rare disease patients in France: A pilot study.
    Pélissier A; Wallut L; Giot G; Domenighetti L; Demougeot L; Faivre L
    Eur J Med Genet; 2022 May; 65(5):104494. PubMed ID: 35385796
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Next-generation sequencing applied to rare diseases genomics.
    Danielsson K; Mun LJ; Lordemann A; Mao J; Lin CH
    Expert Rev Mol Diagn; 2014 May; 14(4):469-87. PubMed ID: 24702023
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Orphan pediatric diseases: regarding the world rare diseases day].
    Gonzales de la Vega L; Hernández-Córdova G; Sobrzano S
    Rev Med Chil; 2013 Feb; 141(2):270-1. PubMed ID: 23732503
    [No Abstract]   [Full Text] [Related]  

  • 75. [Care for patients with rare diseases].
    Smetsers SE; Takkenberg JJ; Bierings MB
    Ned Tijdschr Geneeskd; 2014; 158():A7960. PubMed ID: 25336312
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Rare diseases in paediatrics].
    González-Lamuño D; García Fuentes M
    An Sist Sanit Navar; 2008; 31 Suppl 2():21-9. PubMed ID: 18953370
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Orphan products: hope for people with rare diseases.
    Rados C
    FDA Consum; 2003; 37(6):10-5. PubMed ID: 14986582
    [No Abstract]   [Full Text] [Related]  

  • 78. [Application of modern approaches in the screening and early diagnosis programs for the orphan diseases].
    Gayduk AJ; Vlasov YV; Smirnova DA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(6):30-39. PubMed ID: 35758945
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [GPs: patients require you to doubt! Interview by Catherine Holué].
    Viollet V
    Rev Prat; 2012 Jan; 62(1):85-6. PubMed ID: 22335075
    [No Abstract]   [Full Text] [Related]  

  • 80. Networking in rare cancers: What was done, what's next.
    Frezza AM; Trama A; Blay JY; Casali PG
    Eur J Surg Oncol; 2019 Jan; 45(1):16-18. PubMed ID: 29685758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.